FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 05/31/2013 |
3. Issuer Name and Ticker or Trading Symbol
BELDEN INC. [ BDC ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 3,761 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Appreciation Rights | (1) | 02/24/2019 | Common Stock | 9,000 | $11.92 | D | |
Stock Appreciation Rights | (2) | 02/22/2020 | Common Stock | 13,190 | $21.7 | D | |
Stock Appreciation Rights | (3) | 03/01/2021 | Common Stock | 11,200 | $35.83 | D | |
Stock Appreciation Rights | (4) | 02/27/2022 | Common Stock | 9,950 | $39.83 | D | |
Stock Appreciation Rights | (5) | 03/04/2023 | Common Stock | 6,311 | $50.01 | D |
Explanation of Responses: |
1. 3,000 SARs became exercisable on February 24, 2010, 3,000 SARs became exercisable on February 24, 2011 and 3,000 SARs became exercisable on February 24, 2012. |
2. 4,397 SARs became exercisable on February 22, 2011, 4,397 SARs became exercisable on February 22, 2012 and 4,396 SARs became exercisable on February 22, 2013. |
3. 5,600 SARs became exercisable on March 1, 2012 and were exercised. Of the 11,200 outstanding SARs, 5,600 SARs became exercisable on March 1, 2013 and 5,600 SARs will become exercisable on March 1, 2014. |
4. 3,317 SARs became exercisable on February 27, 2013. The remaining 6,633 SARs are scheduled to become exercisable in equal installments on February 27, 2014 and February 27, 2015. |
5. The SARs will become exercisable in equal installments on each of March 4, 2014, March 4, 2015 and March 4, 2016. |
Remarks: |
/s/ Brian E. Anderson, attorney-in-fact for Glenn Pennycook | 06/03/2013 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |